Skip to main content
finq
OS
Search ticker, company, or fund...
⌘
K
Capture
Closed
ADPT: Adaptive Biotechnologies Corporation Stock Analysis | finqOS
Healthcare · Biotechnology
The Story
ADPT
The Story
ADPT
Loading chart data...
Current State
Balance holding
The verdict
Good business
Weak
Revenue growth
+5.1% / yr
Operating margin
-15.8%
ROIC
-8.6%
Financially safe
Stretched
Debt / equity
2.87×
Interest coverage
-4.0×
Current ratio
4.79×
Adaptive Biotechnologies Corporation
ADPT
NASDAQ Global Select
·
USD
·
Closed
Story
Data
Canvas
Capture
Save
Adaptive Biotechnologies Corporation
ADPT
NASDAQ
·
USD
·
Closed
$22.57
−6.66%
$22.57
−$1.61 (6.66%)
52W Range
86th
pctl
Volume
1.05×
avg
Mkt Cap
3.61B
USD
P/E
-64.7
TTM
Div Yield
–
ann
52W Range
86th
pctl
Volume
1.05×
avg
Market Cap
3.61B
USD
P/E Ratio
-64.7
TTM
Div Yield
-
ann
Overview
Financials
Peers
Sentiment
Analysis
Transcripts
Holders
Company
SEC Filings
Overview
Financials
Peers
Sentiment
Analysis
Transcripts
Holders
Company
SEC Filings